Results 111 to 120 of about 11,585 (220)

Torsade de pointes en una paciente con disfunción de marcapasos VVI

CorSalud, 2020
La torsade de pointes es una taquiarritmia ventricular de gran importancia clínica que aparece típicamente en presencia de un intervalo QT prolongado y que, sin identificación y tratamiento puntual, puede conducir a la muerte súbita cardíaca.
Geordan Goire Guevara, Yassel Arias Otamendy, Marleny Cruz Cardentey, Lázaro Artemio Cuza, Georbis Fournier Calzado, Pedro Rodríguez Peláez, Roger García Kindelán, Yaumara Knight Fernández, Yohelis Cardoza Llacert, Brisis Columbié Hodelin   +9 more
doaj  

Torsade de pointes during an oral surgery caused by a combination of herbal medicine-induced pseudoaldosteronism and trigeminocardiac reflex. [PDF]

Oxf Med Case Reports, 2023
Kawatani Y, Hoshi K, Yamada H, Hori T.
europepmc   +1 more source

Torsade de pointes caused by polypharmacy and substance abuse in a patient with human immunodeficiency virus [PDF]

, 2008
Jane M. Prosser, Angela Mills, Eugene S. Rhim, Jeanmarie Perrone, AJ Moss, RM Gowda, N Singh, SM Al-Khatib, AG Kocheril, A Villa, GA Gamouras, M Gil, I Maremmani, MJ Krantz, CA Kornick, BA Martell, SH Hohnloser   +16 more
core   +1 more source

Az antiaritmiás gyógyszerek proaritmiás hatását befolyásoló tényezők vizsgálata = Examination of the factors that influence the proarrhythmic effects of the antiarrhythmic drugs [PDF]

, 2008
Vizsgálataink során megállapítottuk, hogy az altatószerek módosítják a gyógyszerek proaritmiás hatását nyulakban. Mivel a vagotomia védő hatású volt, a vegetatív idegrendszer valószínűleg befolyásolja a gyógyszerek proaritmiás hatásait nyúlban, de ennek ...
Farkas, András
core  

Effect of Macrolide and Non-Macrolide Therapy on QTc Interval Prolongation in Cardiac Patients with Community-Acquired Pneumonia

Український журнал серцево-судинної хірургії
Introduction. Azithromycin is a macrolide antibiotic widely used to treat various infectious diseases, such as respiratory infections. Several studies have reported an association between azithromycin and QT interval prolongation. QTc prolongation is one
Dwi Akbarina Yahya, Pendrik Tandean, Khalid Saleh, Prerna Mudai, Irawati Djaharuddin, Andi Alfian Zainuddin   +5 more
doaj   +1 more source

Drug-induced QT prolongation and torsade de pointes: a real-world pharmacovigilance study using the FDA Adverse Event Reporting System database. [PDF]

Front Pharmacol, 2023
Li D, Chai S, Wang H, Dong J, Qin C, Du D, Wang Y, Du Q, Liu S.   +8 more
europepmc   +1 more source

Ventricular arrhythmia and torsade de pointe: Dose limiting toxicities of the MDR-modulator S9788 in a phase I trial [PDF]

, 2017
Background: S9788 is a triazineaminopiperidine derivative capable of reversing multidrug resistance (MDR) in vitro. In preclinical models S9788 was several fold more potent MDR inhibitor than verapamil or cyclosporine.
Bastian, G., Bauer, J., Cerny, T., Gerard, B., Giroux, B., Leyvraz, S., Pagani, O., Sarkany, M., Schläpfer, J., Sessa, C., Stupp, R.   +10 more
core  

High-rate pacing suppresses Torsade de Pointes arrhythmias and reduces spatial dispersion of repolarization in the chronic AV-block dog model. [PDF]

Front Physiol, 2023
Loen V, Van Weperen VYH, Beekman HDM, Van Bavel JJA, Meijborg VMF, Van der Waal JG, Coronel R, van der Heyden MAG, Vos MA.   +8 more
europepmc   +1 more source

Establishment and validation of a torsade de pointes prediction model based on human iPSC‑derived cardiomyocytes. [PDF]

Exp Ther Med, 2023
Pan D, Li B, Wang S.
europepmc   +1 more source

A case of short-coupled variant of Torsade de Pointes with bystander early repolarization in inferior leads. [PDF]

J Cardiol Cases, 2023
Takada Y, Kusume T, Terasawa M, Yazaki Y, Satomi K.   +4 more
europepmc   +1 more source